VICP Registry Case Source Bundle
Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_18-vv-01915
Package ID: USCOURTS-cofc-1_18-vv-01915
Petitioner: Anita Anderson
Filed: 2018-12-14
Decided: 2020-12-03
Vaccine: pneumococcal conjugate vaccine
Vaccination date: 2017-10-17
Condition: right shoulder injury related to vaccine administration (SIRVA)
Outcome: compensated
Award amount USD: 45000

AI-assisted case summary:
Anita Anderson filed a petition for compensation under the National Vaccine Injury Compensation Program alleging that she suffered a right shoulder injury related to vaccine administration (SIRVA) from a pneumococcal conjugate vaccine, Prevnar 13, administered on October 17, 2017. She stated that the vaccine was administered in the United States, she suffered residual effects for more than six months, and had no prior award or settlement for her condition. Respondent denied that petitioner sustained a Table SIRVA within the Table timeframe and denied that the vaccine caused her alleged shoulder injury and residual effects. Despite the denial, the parties filed a joint stipulation on June 24, 2020, agreeing that compensation should be awarded. The court found the stipulation reasonable and adopted it as its decision. Anita Anderson was awarded a lump sum of $45,000.00, representing compensation for all items of damages available under the program.

Theory of causation field:
unclear

Public staged source text:

================================================================================
DOCUMENT 1: USCOURTS-cofc-1_18-vv-01915-0
Date issued/filed: 2020-12-03
Pages: 7
Docket text: PUBLIC DECISION (Originally filed: 06/24/2020) regarding 35 DECISION Stipulation/Proffer Signed by Chief Special Master Brian H. Corcoran. (sw) Service on parties made.
--------------------------------------------------------------------------------
Case 1:18-vv-01915-UNJ Document 44 Filed 12/03/20 Page 1 of 7
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
No. 18-1915V
UNPUBLISHED
ANITA ANDERSON, Chief Special Master Corcoran
Petitioner, Filed: June 24, 2020
v.
Special Processing Unit (SPU); Joint
SECRETARY OF HEALTH AND Stipulation on Damages;
HUMAN SERVICES, Pneumococcal Conjugate Vaccine;
Shoulder Injury Related to Vaccine
Respondent. Administration (SIRVA)
Michael G. McLaren, Black McLaren Jones Ryland & Griffee, P.C., Memphis, TN, for
petitioner.
Voris Edward Johnson, U.S. Department of Justice, Washington, DC, for respondent.
DECISION ON JOINT STIPULATION1
On December 14, 2018, Anita Anderson filed a petition for compensation under
the National Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et seq.2 (the
“Vaccine Act”). Petitioner alleges that she suffered a right shoulder injury related to
vaccine administration (“SIRVA”) from a pneumococcal conjugate vaccine, Prevnar 13,
administered on October 17, 2017. Petition at 1; Stipulation, issued at June 24, 2020,
¶¶ 1-4. Petitioner further alleges that the vaccine was administered in the United
States, she suffered the residual effects of her SIRVA for more than six months, and
that there has been no prior award or settlement of a civil action for damages as a result
of her condition. Petition at 1-3; Stipulation at ¶¶ 3-5. “Respondent denies that
petitioner sustained a Table SIRVA within the Table timeframe, and denies that the
Prevnar 13 vaccine in fact caused her alleged shoulder injury and residual effects, or
any other injury.” Stipulation at ¶ 6.
1 Because this unpublished decision contains a reasoned explanation for the action in this case, I am
required to post it on the United States Court of Federal Claims' website in accordance with the E-
Government Act of 2002. 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of
Electronic Government Services). This means the decision will be available to anyone with access
to the internet. In accordance with Vaccine Rule 18(b), Petitioner has 14 days to identify and move to
redact medical or other information, the disclosure of which would constitute an unwarranted invasion of
privacy. If, upon review, I agree that the identified material fits within this definition, I will redact such
material from public access.
2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for
ease of citation, all “§” references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C.
§ 300aa (2012).

Case 1:18-vv-01915-UNJ Document 44 Filed 12/03/20 Page 2 of 7
Nevertheless, on June 24, 2020, the parties filed the attached joint stipulation,
stating that a decision should be entered awarding compensation. I find the stipulation
reasonable and adopt it as my decision awarding damages, on the terms set forth
therein.
Pursuant to the terms stated in the attached Stipulation, I award the following
compensation:
A lump sum of $45,000.00 in the form of a check payable to Petitioner.
Stipulation at ¶ 8. This amount represents compensation for all items of
damages that would be available under § 15(a). Id.
I approve the requested amount for Petitioner’s compensation. In the absence of
a motion for review filed pursuant to RCFC Appendix B, the clerk of the court is directed
to enter judgment in accordance with this decision.3
IT IS SO ORDERED.
s/Brian H. Corcoran
Brian H. Corcoran
Chief Special Master
3 Pursuant to Vaccine Rule 11(a), entry of judgment can be expedited by the parties’ joint filing of notice
renouncing the right to seek review.
2

Case 1:18-vv-01915-UNJ Document 44 Filed 12/03/20 Page 3 of 7

Case 1:18-vv-01915-UNJ Document 44 Filed 12/03/20 Page 4 of 7

Case 1:18-vv-01915-UNJ Document 44 Filed 12/03/20 Page 5 of 7

Case 1:18-vv-01915-UNJ Document 44 Filed 12/03/20 Page 6 of 7

Case 1:18-vv-01915-UNJ Document 44 Filed 12/03/20 Page 7 of 7